Page last updated: 2024-11-03

risperidone and Facial Dermatoses

risperidone has been researched along with Facial Dermatoses in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Facial Dermatoses: Skin diseases involving the FACE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lowry, CL1
Bewley, A1
Taylor, R1
Maio, P1
Santos, R1
Cardoso, J1

Other Studies

2 other studies available for risperidone and Facial Dermatoses

ArticleYear
Facial ulcer treated with olanzapine.
    Clinical and experimental dermatology, 2013, Volume: 38, Issue:5

    Topics: Aged; Benzodiazepines; Dopamine Antagonists; Drug Substitution; Facial Dermatoses; Female; Histamine

2013
Letter: Factitial dermatitis: an unusual presentation in an old woman.
    Dermatology online journal, 2012, Apr-15, Volume: 18, Issue:4

    Topics: Aged; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Facial Dermatoses; Factitious Disorders

2012